Theralase Technologies Inc. V.TLT

Interim Financials

[Mikee3003]

Not bad...one more treated since the April 28th newsletter.



Theralase Releases Q12021 Interim Financial Statements


Mikee

[Pandora]

  Theralase loses $919,093 in Q1 2021   2021-05-28 19:14 ET - News Release   Ms. Kristina Hachey reports THERALASE RELEASES Q12021 INTERIM FINANCIAL STATEMENTS Theralase Technologies Inc. has released its unaudited Q1 2021 condensed interim consolidated financial statements. Total revenue remained predominantly flat, year over year, and

[99942Apophis]

Mikee3003 wrote Not bad...one more treated since the April 28th newsletter. Theralase Releases Q12021 Interim Financial Statements Mikee Thanks Mikee3003 gives us 22 including 3 from PH1 which I forgot to include in my last post, now all thats needed is 3 which has a high chance of being achieved in the month of June.

[riverrrow]

10 trial sites have managed to treat one patient in the past month. I'm not impressed.

[greaterfoolFred]

I keep trying to tell you folks to curb your enthusiasm.  Some of you have unreasonable expectations.  This trial is a little more complicated than just a simple drug trial where you ship out some pills and a set of instructions.  We have to ship out sophisticated equipment, then send a technician to set it up and verify its operation.  Then we have to send someone to train

[floatinketucky]

I think the trial is going great. The CEO is involed with scheduling patients. The Burn Rate is low. The company is moving nicely towards the guidance from the FDA for approval.  Theralase is in their new lab.  It's looking good here!   $TLTFF  Long

[floatinketucky]

Shawn Shirazi PhD, Chief Executive Officer, Theralase®, stated, "It is truly uplifting to be working on the details of getting patients enrolled and treated at these sites. 

[Yajne]

float...I agree all of that is great, but if they could throw out a bone or two to perk things up a bit, that would be even more awesome! Long time shareholders deserve nothing less....